Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | +1.72% | +12.38% | +8.26% |
Financials (USD)
Sales 2024 * | 17.54M | Sales 2025 * | 14.63M | Capitalization | 219M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -25M | EV / Sales 2024 * | 12.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-9.37
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on Lineage Cell Therapeutics, Inc.
1 day | +1.72% | ||
1 week | +12.38% | ||
Current month | +8.26% | ||
1 month | -15.71% | ||
3 months | +9.26% | ||
6 months | +10.28% | ||
Current year | +8.26% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Director/Board Member | 66 | 14-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.18 | +1.72% | 716,352 |
24-05-08 | 1.16 | -7.94% | 915,518 |
24-05-07 | 1.26 | -3.08% | 1,221,577 |
24-05-06 | 1.3 | +22.64% | 4,103,213 |
24-05-03 | 1.06 | +0.95% | 614,788 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.26% | 219M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- LCTX Stock